Skip to main content

Table 1 Patients analyzeda

From: Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis

Patient characteristics ABCoN (N= 98) Nested I (N= 64) Control (N= 102)
Mean (SD) age, years 54.8 (12.8) 52.6 (13.3) 55.9 (13.0)
Sex (female), n (%) 75 (78)b 53 (83) 77.4
Mean (SD) disease duration, years 10.3 (9.0) 9.2 (11.6)b NA
Mean (SD) disease activity, DAS28 score 5.16 (0.95) 5.62 (0.91) NA
RF-positive, n (%) 81 (87.1) 45 (70.3)b NA
ACPA-positive, n (%) 75 (80.5) 37 (74.0)b NA
Mean (SD) sG0/G1 1.37 (0.42) 1.38 (0.41) 1.02 (0.25)
  1. a ABCoN, Autoimmune Biomarkers Collaborative Network; ACPA, Anti-Citrullinate Peptide Antibody; DAS28, 28-joint Disease Activity Score; RF, rheumatoid factor; sG0/G1, ratio of agalactosylated to monogalactosylated N-glycans in serum. bFractions represent proportions within available data. ABCoN gender data available in 96 patients; Nested I, disease duration available in 62 patients, RF in 63 and ACPA in 50 patients.